Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Med.

Sec. Obstetrics and Gynecology

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1642095

Clinical Symptom Improvement and Lipidomic Signatures in Overweight/Obese PCOS Treated by Lifestyle and Acupuncture Intervention

Provisionally accepted
Hao-Lin  ZhangHao-Lin Zhang1Wenmin  TianWenmin Tian2Dong  LiDong Li1Yang  ChenYang Chen2Yang  YeYang Ye1Zejun  HuoZejun Huo1Li  ShiLi Shi1Ii  FukuzawaIi Fukuzawa1Shuhan  YangShuhan Yang1Yang  YangYang Yang1Hua  ZhangHua Zhang1Lin  ZengLin Zeng1Xiyan  XinXiyan Xin1Chunyong  WangChunyong Wang1Wen  MaWen Ma2Weiyu  QiuWeiyu Qiu1Zhihui  QiZhihui Qi1Heng  DaiHeng Dai1Na  LiNa Li1Haining  WangHaining Wang1*Rong  LiRong Li1*
  • 1Peking University Third Hospital, Haidian, China
  • 2Peking University, Beijing, China

The final, formatted version of the article will be published soon.

Background: polycystic ovary syndrome (PCOS) is interrelated with obesity. Lifestyle intervention, mainly focusing on weight loss, has emerged as promising strategies to improve fertility outcomes in women with obesity. Acupuncture can aid in weight loss through metabolic regulation. However, evaluating the effectiveness of lifestyle and acupuncture in improving symptoms of polycystic ovary syndrome is still lacking. Results: this study aims to evaluate the efficacy of long-term lifestyle and acupuncture treatment on PCOS and elucidate the lipidomic features of these interventions in patients with overweight/obese PCOS, and identify potential therapeutic targets. Thirty-one women with PCOS and twenty-eight age and BMI matched controls were recruited. The participants with PCOS were randomly assigned to either Lifestyle and acupuncture intervention group (A&L) or Lifestyle and sham acupuncture group (SA&L) for 4 months. The patients were followed up for an additional 4 months. Clinical indices indicating hyperandrogenism, homeostasis and quality of life was collected to evaluate the effectiveness of treatments. Comprehensive lipidomic analyses by utilizing mass spectrometry were conducted to profile the lipidomic signatures of participants with PCOS before and after treatment. After the A&L intervention, the BMI of participants with PCOS was significantly reduced. Assessments of insulin resistance (HbA1c, HOMA-IR, ISI), hyperandrogenism (SHBG, FAI), physical activity, and β-endorphin showed significant improvement. Lipidomic analysis revealed a panel of lipid species that effectively distinguished participants with PCOS from those without PCOS (AUC=0.9747). Serum 18:0 Lyso PI, involved in intracellular insulin signaling pathways, was specifically associated with the A&L regimen. The co-regulation of 18:0 Lyso PI and 16:0 SM (d18:1/16:0) were associated with the A&L regimen. Conclusions: 18:0 Lyso PI may be a potential biomarker for A&L therapy in PCOS patients.

Keywords: Lifestyle and acupuncture intervention, Polycystic ovary syndrome (PCOS), Body mass index (BMI), Insulin Resistance, lipidomic

Received: 06 Jun 2025; Accepted: 11 Sep 2025.

Copyright: © 2025 Zhang, Tian, Li, Chen, Ye, Huo, Shi, Fukuzawa, Yang, Yang, Zhang, Zeng, Xin, Wang, Ma, Qiu, Qi, Dai, Li, Wang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Haining Wang, Peking University Third Hospital, Haidian, China
Rong Li, Peking University Third Hospital, Haidian, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.